Year: 1999
Type: article
Abstract: A select population of autoimmune T helper (Th) cells drives B cells to produce pathogenic anti-DNA autoantibodies in systemic lupus erythematosus (SLE) (1-3).To identify their immunogen(s), the autoimmune Th cells of lupus were cloned from patients with SLE, as well as from the (SWR × NZB)F 1 (SNF 1 ) mice that spontaneously develop lupus nephritis (1, 2, 4-6).In lupusprone mice, a majority of such pathogenic Th clones respond to nucleosomal antigens, and nucleosome-specific T cells are detectable early in the mice, long before they begin to produce pathogenic autoantibodies (3, 6, 7).Pathogenic autoantibody-inducing Th cells of human lupus are also specific for nucleosomal antigens (3, 8), and nucleosome-specificity of the autoantibodies that are induced by such Th cells probably mediates glomerular binding and the development of lupus nephritis (6, 9-12).Thus nucleosomes are primary immunogens that might initiate the cognate interaction between pathogenic Th and B cells of lupus.Nucleosomes can be released from apoptotic cells even in normal subjects (13, 14), but the spontaneous expansion of nucleosome-reactive T cells occurs in lupus-prone mice (6, 7).These Th cells are essential for sustaining the pathogenic autoantibody-producing B cells of lupus (15, 16).Herein, we have identified the peptide autoepitopes in nucleosomes that are recurrently recognized by the autoimmune T cells of patients with SLE. MethodsPatients and healthy donors.Short-term CD4 T-cell lines were derived from 5 patients with active lupus (all female; aged 18-50 years), 5 patients in long-term remission (all female; aged 21-51 years), and 6 normal (healthy) subjects (2 male and 4 female; aged 24-52 years), as described previously (17).PBMCs from another set of 8 patients with lupus in long-term remission (2 male and 6 female; aged 28-55 years), and 4 patients with active lupus (all female; aged 22-47 years), were studied directly for intracellular cytokine production.Disease activity by Systemic Lupus Activity Measure (SLAM; ref. 18) ranged between 7 and 20 for patients with active lupus.None of the patients in remission had detectable proteinuria or serum anti-DNA autoantibodies at the time of testing, and their SLAM ranged between 0 and 4. The patients in remission had never received any cytotoxic drugs.Steroids had been discontinued for several years in the patients in remission, except for 2 who had received a short course of low-dose steroids (prednisone, 10 mg/d) 2 months before their blood samples were drawn for the assays.Antibodies.Anti-CD3 (OKT3) mAb was obtained from American Type Culture Collection (Rockville, Maryland, USA).Anti-CD28 mAb (clone 9.3) was provided by Kathy Cabrian (Bristol-Myers Squibb, Seattle, Washington, USA).Purified mAb's for ELISA, phycoerythrinconjugated (PE-conjugated) mAb to human IL-10, and
DOI: 10.1172/jci6801
Institutions: Northwestern University, National Institutes of Health
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2121359611
